Deprecated: Creation of dynamic property lastRSS::$cache_dir is deprecated in /www/wwwroot/forexconverter.org/00rss.php on line 45
Deprecated: Creation of dynamic property lastRSS::$cache_sqlite is deprecated in /www/wwwroot/forexconverter.org/00rss.php on line 46
Deprecated: Creation of dynamic property lastRSS::$cache_time is deprecated in /www/wwwroot/forexconverter.org/00rss.php on line 47
Deprecated: Creation of dynamic property lastRSS::$rsscp is deprecated in /www/wwwroot/forexconverter.org/lastRSS.php on line 234
Medicare GLP-1 Bridge: GLP-1 Drugs for $50 a Month How to get GLP-1 drugs through Medicare GLP-1 Bridge • Talk to your doctor about whether a GLP-1 drug is right for you and if you qualify for this program • If one of the drugs covered is right for you, your doctor will send a prescription to the pharmacy • Your pharmacy may reach out to you to request your Medicare ID number
Medicare GLP-1 Bridge: How to Get Wegovy or Zepbound for $50 . . . Quick Answer: The Medicare GLP-1 Bridge is a temporary CMS program running from July 1st, 2026, through December 31st, 2027 Eligible Medicare Part D members who meet specific BMI and health criteria can get Wegovy, Zepbound KwikPen, or Foundayo for a $50 monthly copay You start with a prescriber, not directly with Medicare
How to Get Wegovy or Zepbound for $50 on Medicare GLP-1 Insurance Coverage Articles How to Get Wegovy or Zepbound for $50 on Medicare By Jordy • May 2, 2026 • Updated October 20, 2026 • 4 min read
Weight loss drugs | Medicare Description GLP-1 drugs can help you manage your weight and improve your health Starting July 1, 2026, Medicare covers these GLP-1 drugs: Foundayo® (tablet) Wegovy® (injection or tablet) Zepbound® (KwikPen® only The program doesn’t cover single-dose Zepbound® vials or pens)
Medicare GLP-1 Bridge Checklist: Qualify for $50 Month Wegovy . . . Quick answer Medicare’s GLP-1 Bridge lets people with Part D drug coverage get Wegovy, Zepbound or Foundayo for weight loss for a flat $50 a month, from July 1, 2026, through December 31, 2027 You qualify with a BMI of 35 or higher, or a BMI of 27 or higher plus a qualifying condition such as heart disease or prediabetes Your prescriber submits a prior authorization, and once approved you